We serve Chemical Name:(±)-Anabasine CAS:13078-04-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(±)-Anabasine
CAS.NO:13078-04-1
Synonyms:(R,S)-3-(2-Piperidinyl)Pyridine;3-(piperidin-2-yl)pyridine;Pyridine, 3-(2-piperidinyl)-;Anabasine;MFCD00006370;(±)-Anabasine;DL-Anabasine;3-Piperidin-2-ylpyridine;(R,S)-Anabasine;3-(2-Piperidinyl)pyridine;(-)-ANABASINE
Molecular Formula:C10H14N2
Molecular Weight:162.232
HS Code:2933990090
Physical and Chemical Properties:
Melting point:9ºC
Boiling point:271.0±0.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.524
PSA:24.92000
Exact Mass:162.115692
LogP:0.85
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3140 6.1/PG 2
Packing Group:I
Contact us for information like (R,S)-3-(2-Piperidinyl)Pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(-)-ANABASINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(-)-ANABASINE Use and application,(R,S)-3-(2-Piperidinyl)Pyridine technical grade,usp/ep/jp grade.
Related News: In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. (±)-Anabasine manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. (±)-Anabasine supplier According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. (±)-Anabasine vendor AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. (±)-Anabasine factory In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.
